The PI3K/Akt/mTOR signaling pathway is overexpressed in nearly 50% of hepatocellular carcinoma cases, and its abnormal activation affects cell proliferation, metabolism, tumor cell differentiation, lipid metabolism, autophagy and EMT [18, 19]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.